Osborne Clarke has advised Brightlands Venture Partners and TechVision Fonds on the deal.The Aachen-based organ vitality tech company Vivalyx GmbH has received an investment of 5.4…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Marco Zingaro
…
This content is for Standard 1 Year members only. LoginJoin Now